Idiopathic portal hypertension with regard to thiopurine treatment.
暂无分享,去创建一个
[1] J. Panero,et al. Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease. , 2016 .
[2] C. Mulder,et al. Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement , 2015, PloS one.
[3] S. Hanauer,et al. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease. , 2011, Journal of Crohn's & colitis.
[4] R. Stockbrügger,et al. Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects? , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[5] S. Schoenberg,et al. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy. , 2006, European journal of gastroenterology & hepatology.